Quantcast
 
New ETF Book by Larry Connors - Click here to read more


NOVN

Japan's Hisamitsu secures 87% stake in US drugmaker via tender - 08/24 - 12:40 AM ET

JAPAN'S HISAMITSU CLINCHES 87% STAKE IN US DRUGMAKER VIA TENDER - 08/24 - 12:25 AM ET

Noven Pharmaceuticals Inc. (NOVN) Corporate Event Announcement Notice - 08/08 - 08:56 PM ET

Kendall Law Group Announces Lawsuit on Behalf of Noven Shareholders - 07/22 - 02:12 PM ET

Noven Reveals Phase 2 Findings for Mesafem Non-Hormonal Therapy for Vasomotor Symptoms - 07/20 - 11:48 PM ET

Noven and Hisamitsu Ink Definitive Merger Pact - 07/20 - 11:48 PM ET

Noven Pharmaceuticals Closed At New 52-Week High Tuesday - 07/15 - 08:55 AM ET

Noven Pharmaceuticals to be purchased by Japanese firm: Noven Pharmaceuticals of South Miami-Dade is being sold to a Japanese company for $428 million in an all-stock transaction that is not expected to result in any job losses. - 07/15 - 04:44 AM ET

BRIEF: Noven Pharmaceuticals to be purchased by Japanese firm - 07/14 - 04:09 PM ET

Noven reports positive results from Phase II hot flashes trial - 07/14 - 01:14 PM ET

Noven Pharmaceuticals to be purchased by Japanese firm - 07/14 - 12:08 PM ET

Noven Pharmaceuticals (NOVN) Mature Trend: 67.3% Move in 112 Days - 07/14 - 10:13 AM ET

NOVN: Positive Phase 2 Results for Mesafem(TM) for Menopausal "Hot Flashes" - 07/14 - 09:36 AM ET

NOVN: Hisamitsu Pharmaceutical to Acquire for $16.50 Per Share - 07/14 - 09:33 AM ET

SmarTrend(R) News Watch: Hisamitsu Pharmaceuticals Acquires Noven Pharmaceuticals - 07/14 - 07:14 AM ET

Noven Reports Positive Phase 2 Results for Mesafem(TM) Non-Hormonal Therapy for Vasomotor Symptoms - 07/14 - 06:41 AM ET

Noven and Hisamitsu Enter into Definitive Merger Agreement - 07/14 - 06:39 AM ET

Noven Pharmaceuticals Closed Thursday At New High For Year - 06/26 - 08:45 AM ET

Noven Pharmaceuticals (NOVN) Established Trend: 40.1% Move in 93 Days - 06/25 - 06:23 PM ET

NOVN touches 200-day moving average at 11.48 - 05/26 - 09:03 AM ET

Page 1 of 3     1  2   3      Previous  |  Next

<< Back to Stock Index

 

Most Popular News
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.